Panion & Bf Biotech (TPE:1760) Dividend Payout Ratio: 3.91 (As of Jun. 2026) — 408% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1760 Panion & Bf Biotech Inc TPE:1760
73 GF Score
Price NT$59.00
GF Value NT$86.45
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Panion & Bf Biotech Dividend Payout Ratio?

Panion & Bf Biotech TPE:1760 +0.34% 73 Dividend Payout Ratio is 3.91 as of Jun. 2026, which is 408% above its 10-year median of 0.77. GuruFocus rates TPE:1760 with a GF Score™ of 73/100 and a GF Value™ of NT$86.45 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 451 Drug Manufacturers companies, Panion & Bf Biotech ranks worse than 81.6% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Panion & Bf Biotech's Dividend Payout Ratio for the months ended in Jun. 2026 was 3.91.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Panion & Bf Biotech Inc is 0.72, which seems too high.

The historical rank and industry rank for Panion & Bf Biotech's Dividend Payout Ratio or its related term are showing as below:

TPE:1760' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.5   Med: 0.77   Max: 4.49
Current: 0.72

During the past 13 years, the highest Dividend Payout Ratio of Panion & Bf Biotech was 4.49. The lowest was 0.50. And the median was 0.77.

TPE:1760's Dividend Payout Ratio is ranked worse than
81.6% of 451 companies
in the Drug Manufacturers industry
Industry Median: 0.37 vs TPE:1760: 0.72

As of today (2026-08-22), the Dividend Yield % of Panion & Bf Biotech is 3.05%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Panion & Bf Biotech was 4.00%. The lowest was 0.26%. And the median was 1.68%.

Panion & Bf Biotech's Dividends per Share for the months ended in Jun. 2026 was NT$1.80.

During the past 3 years, the average Dividends Per Share Growth Rate was 6.30% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 8.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 19.20% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Panion & Bf Biotech was 141.50% per year. The lowest was -22.40% per year. And the median was 17.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Panion & Bf Biotech (TPE:1760) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Panion & Bf Biotech Dividend Payout Ratio Related Terms

Panion & Bf Biotech Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Panion & Bf Biotech's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panion & Bf Biotech Dividend Payout Ratio Chart

Panion & Bf Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.71 2.25 1.04 0.81

Panion & Bf Biotech Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.11 0.00 0.00 0.00 3.91

TPE:1760 vs ZTS: Dividend Payout Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Panion & Bf Biotech's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panion & Bf Biotech Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Panion & Bf Biotech's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Panion & Bf Biotech's Dividend Payout Ratio falls into.


TPE:1760
73GF Score
Panion & Bf Biotech Inc TPE:1760
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Panion & Bf Biotech Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Panion & Bf Biotech's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=1.8/ 2.216
=0.81

Panion & Bf Biotech's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=1.8/ 0.461
=3.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 3.91 mean?
Panion & Bf Biotech (TPE:1760) has a Dividend Payout Ratio of 3.91 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Panion & Bf Biotech and its competitors. This is 408% above median its historical median of 0.77. Over the past decade, Panion & Bf Biotech's Dividend Payout Ratio has ranged from 0.50 to 4.49. According to the industry distribution chart, Panion & Bf Biotech ranks #368 out of 451 companies in the Drug Manufacturers industry, placing it in the top 81.6%.
Is Panion & Bf Biotech's Dividend Payout Ratio too high?
Panion & Bf Biotech's current Dividend Payout Ratio of 3.91 is 408% above median its 10-year median of 0.77. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 4.49. The Drug Manufacturers industry median Dividend Payout Ratio is 0.37. Panion & Bf Biotech's value of 3.91 is 956.8% above this industry median. Based on the distribution chart, Panion & Bf Biotech ranks #368 out of 451 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Panion & Bf Biotech has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Panion & Bf Biotech's Dividend Payout Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Panion & Bf Biotech ranks #368 out of 451 companies for Dividend Payout Ratio. This places Panion & Bf Biotech in the lower half of its industry. The industry median Dividend Payout Ratio is 0.37. Panion & Bf Biotech's value of 3.91 is 956.8% above this benchmark. Historically, Panion & Bf Biotech's own Dividend Payout Ratio has ranged from 0.50 to 4.49 over the past decade. While the company's 10-year median is 0.77 vs. the industry median of 0.37, Panion & Bf Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.37, based on 451 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Panion & Bf Biotech's current Dividend Payout Ratio of 3.91 is 956.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Panion & Bf Biotech and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Panion & Bf Biotech's current Dividend Payout Ratio is 3.91, which is 408% above median its own 10-year median of 0.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panion & Bf Biotech stock overvalued right now?
Based on GuruFocus' analysis, Panion & Bf Biotech (TPE:1760) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$86.45, compared to a current price of NT$59.00 — trading 31.8% below its estimated fair value. The current Dividend Payout Ratio is 3.91, which is 408% above median its 10-year median of 0.77 and 956.8% above the Drug Manufacturers industry median of 0.37. Panion & Bf Biotech's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Panion & Bf Biotech (TPE:1760), the current Dividend Payout Ratio is 3.91 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Panion & Bf Biotech (TPE:1760) Overvalued in 2026?

Based on GuruFocus' analysis, Panion & Bf Biotech stock appears to be undervalued. The current stock price of NT$59.00 is trading 31.8% below its estimated GF Value™ of NT$86.45. GuruFocus considers Panion & Bf Biotech to be Significantly Undervalued.

Key valuation signals for TPE:1760:

  • Dividend Payout Ratio: 3.91 (408% above median its 10-year median of 0.77)
  • GF Value™: NT$86.45 vs. price of NT$59.00 (31.8% below fair value)
  • GF Score™: 73/100 with 3 warning signs
  • Industry Position: 956.8% above the Drug Manufacturers median (#368 of 451)

No single metric tells the full story. See the TPE:1760 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Panion & Bf Biotech Business Description

Address No. 3, Park Street, 16th Floor, Nangang District, Taipei, TWN, 11503
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. The company, along with its subsidiaries, is mainly engaged in the manufacture and sales of pharmaceutical, cosmeceutical, diagnostic, medical device, and active pharmaceutical ingredients. It has four core business groups: disease treatment, disease prevention, disease diagnosis, and delayed aging. It has geographic segments in Taiwan; China, Hong Kong, and Macau; the USA; and Korea. It generates a majority of its revenue from the Taiwan segment. Product-wise the firm generates the majority of its revenue from Pharmaceutical products.
73GF Score

Get the complete analysis for TPE:1760

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$59.00
Price
NT$86.45
GF Value